Breast Cancer Trial, Recruiting NCT04843865 Sponsor: Universiti Tunku Abdul Rahman Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT04843865
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman who has gone through menopause (your periods stopped at least 1 year ago, or a blood test confirms this)
  • You have been diagnosed with stage 2 or 3 breast cancer that is hormone-receptor positive (confirmed by a tissue test)
  • You have been taking the medication letrozole for at least 1 month
  • You are experiencing ongoing joint or muscle pain or stiffness that started or got worse after you began taking letrozole
  • Your pain has scored 4 or higher (out of 10) on average over the past week
  • You have already finished all planned surgery, chemotherapy, and radiation treatment
  • You are willing to take prescribed Chinese herbal medicine as part of the trial
  • There is no sign that your cancer has spread to other parts of your body
  • You are able to attend all follow-up appointments for the full length of the study
  • You have not had any sudden new illness in the past month
  • You are able to communicate with the study team
  • You are willing to give your written agreement to take part

Who may not be able to join:

  • You are pregnant, breastfeeding, or could become pregnant and are not using a reliable form of contraception
  • You have missed appointments or have an irregular history of attending follow-up visits
  • You are currently taking part in another clinical study at the same time
  • You have a history of not following medical instructions or are unwilling to follow the study plan
  • You are bedridden or your cancer has spread to your bones or lungs
  • You currently have an infection that requires antibiotics given through a drip (intravenously)
  • You have a known allergy to Chinese herbal medicine
  • You have previously used Chinese herbal medicine specifically to treat joint or muscle symptoms caused by your breast cancer medication
  • You have taken any Chinese herbal medicine within the month before joining the study
  • You have used steroids or strong painkillers (narcotics) for pain relief in the past 2 weeks
  • You have a new flare-up of a long-term illness or have had any sudden illness in the past month
  • You have certain serious health conditions, including poorly controlled high blood pressure, underactive thyroid, diabetes, liver disease, osteoarthritis, rheumatoid arthritis, gout, nerve-related joint problems, autoimmune or inflammatory joint conditions, a recent bone fracture, or a history of stroke (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universiti Tunku Abdul Rahman
Registry
ClinicalTrials.gov
Start date
22 April 2022
Est. completion
1 December 2024

Where this trial is recruiting

🇲🇾 Malaysia

Primary endpoints

Feasibility of the study (Adherence)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov